0002160802-26-000001.txt : 20261022 0002160802-26-000001.hdr.sgml : 20261022 20261021213344 ACCESSION NUMBER: 0002160802-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Section 4(A)(5) exempts sales of securities to accredited investors when the total offering is less than $5,000,000 FILED AS OF DATE: 20261022 DATE AS OF CHANGE: 20261021 EFFECTIVENESS DATE: 20261022 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LeanBio Therapeutics, Inc. CENTRAL INDEX KEY: 0002160802 ORGANIZATION NAME: EIN: 424054744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-602128 FILM NUMBER: 261477022 BUSINESS ADDRESS: STREET 1: 80 PARK STREET STREET 2: APT PH CITY: BROOKLINE STATE: MA ZIP: 02446 BUSINESS PHONE: 716-6557788 MAIL ADDRESS: STREET 1: 931 PORTERVILLE ROAD CITY: EAST AURORA STATE: NY ZIP: 14052 D 1 primary_doc.xml X0708 D LIVE 0002160802 LeanBio Therapeutics, Inc. 80 PARK STREET APT PH BROOKLINE MA MASSACHUSETTS 02446 716-6557788 DELAWARE None None Corporation true 2026 Michal Preminger 80 Park Street Apt PH Brookline MA MASSACHUSETTS 02446 Executive Officer Director William Hait 80 Park Street Apt PH Brookline MA MASSACHUSETTS 02446 Executive Officer Director Biotechnology No Revenues 06b 4a5 false true true true true true false 0 Indefinite 0 Indefinite false 0 0 0 0 false LeanBio Therapeutics, Inc. /s/ Brian W. Pusch Brian W. Pusch Secretary 2026-10-21